Identification by high-throughput imaging of the histone methyltransferase EHMT2 AS an epigenetic regulator of VEGFA alternative splicing

Nucleic Acids Research

Volumn 42, Issue 22, 2014, Pages 13662-13672

  Salton, Maayan ^a   Voss, Ty C ^a   Misteli, Tom ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HETEROCHROMATIN PROTEIN 1; HETEROCHROMATIN PROTEIN 1GAMMA; HISTONE METHYLTRANSFERASE; MESSENGER RNA; PEPTIDES AND PROTEINS; PROTEIN EHMT1; PROTEIN EHMT2; PROTEIN SRSF1; UNCLASSIFIED DRUG; CBX3 PROTEIN, HUMAN; CHROMATIN; EHMT2 PROTEIN, HUMAN; HISTOCOMPATIBILITY ANTIGEN; HISTONE LYSINE METHYLTRANSFERASE; NONHISTONE PROTEIN; NUCLEAR PROTEIN; RNA BINDING PROTEIN; SERINE ARGININE RICH SPLICING FACTOR; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ALTERNATIVE RNA SPLICING; ARTICLE; CHROMATIN; CONTROLLED STUDY; EPIGENETICS; EXON; GENE; GENETIC REGULATION; GENETIC TRANSCRIPTION; HIGH THROUGHPUT SCREENING; HISTONE METHYLATION; HUMAN; HUMAN CELL; HYPOXIA; PRIORITY JOURNAL; PROTEIN BINDING; VEGFA GENE; CELL HYPOXIA; FLUORESCENCE MICROSCOPY; GENETIC EPIGENESIS; GENETICS; HEK293 CELL LINE; MCF 7 CELL LINE; METABOLISM; PHYSIOLOGY; RNA INTERFERENCE; TUMOR CELL LINE;

ALTERNATIVE SPLICING; CELL HYPOXIA; CELL LINE, TUMOR; CHROMATIN; CHROMOSOMAL PROTEINS, NON-HISTONE; EPIGENESIS, GENETIC; HEK293 CELLS; HISTOCOMPATIBILITY ANTIGENS; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; MCF-7 CELLS; MICROSCOPY, FLUORESCENCE; NUCLEAR PROTEINS; RNA INTERFERENCE; RNA-BINDING PROTEINS; SERINE-ARGININE SPLICING FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84927585191     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku1226     Document Type: Article

References (64)

1. Maniatis, T. and Reed, R. (2002) An extensive network of coupling among gene expression machines. Nature, 416, 499-506.
2. Luco, R. F., Allo, M., Schor, I. E., Kornblihtt, A. R. and Misteli, T. (2011) Epigenetics in alternative pre-mRNA splicing. Cell, 144, 16-26.
3. Bentley, D. L. (2014) Coupling mRNA processing with transcription in time and space. Nat. Rev. Genet., 15, 163-175.
4. Graveley, B. R. (2001) Alternative splicing: increasing diversity in the proteomic world. Trends Genet., 17, 100-107.
5. Pan, Q., Shai, O., Lee, L. J., Frey, B. J. and Blencowe, B. J. (2008) Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat. Genet., 40, 1413-1415.
6. Wang, E. T., Sandberg, R., Luo, S., Khrebtukova, I., Zhang, L., Mayr, C., Kingsmore, S. F., Schroth, G. P. and Burge, C. B. (2008) Alternative isoform regulation in human tissue transcriptomes. Nature, 456, 470-476.
7. Barash, Y., Calarco, J. A., Gao, W., Pan, Q., Wang, X., Shai, O., Blencowe, B. J. and Frey, B. J. (2010) Deciphering the splicing code. Nature, 465, 53-59.
8. Irimia, M. and Blencowe, B. J. (2012) Alternative splicing: decoding an expansive regulatory layer. Curr. Opin. Cell Biol., 24, 323-332.
9. Schwartz, S., Meshorer, E. and Ast, G. (2009) Chromatin organization marks exon-intron structure. Nat. Struct. Mol. Biol., 16, 990-995.
10. Andersson, R., Enroth, S., Rada-Iglesias, A., Wadelius, C. and Komorowski, J. (2009) Nucleosomes are well positioned in exons and carry characteristic histone modifications. Genome Res., 19, 1732-1741.
11. Zhou, H. L., Luo, G., Wise, J. A. and Lou, H. (2014) Regulation of alternative splicing by local histone modifications: potential roles for RNA-guided mechanisms. Nucleic Acids Res., 42, 701-713.
12. Gunderson, F. Q. and Johnson, T. L. (2009) Acetylation by the transcriptional coactivator Gcn5 plays a novel role in co-transcriptional spliceosome assembly. PLoS Genet., 5, e1000682.
13. Kornblihtt, A. R., Schor, I. E., Allo, M., Dujardin, G., Petrillo, E. and Munoz, M. J. (2013) Alternative splicing: a pivotal step between eukaryotic transcription and translation. Nat. Rev. Mol. Cell Biol., 14, 153-165.
14. Cramer, P., Pesce, C. G., Baralle, F. E. and Kornblihtt, A. R. (1997) Functional association between promoter structure and transcript alternative splicing. Proc. Natl Acad. Sci. U. S. A., 94, 11456-11460.
15. Roberts, G. C., Gooding, C., Mak, H. Y., Proudfoot, N. J. and Smith, C. W. (1998) Co-transcriptional commitment to alternative splice site selection. Nucleic Acids Res., 26, 5568-5572.
16. Luco, R. F., Pan, Q., Tominaga, K., Blencowe, B. J., Pereira-Smith, O. M. and Misteli, T. (2010) Regulation of alternative splicing by histone modifications. Science, 327, 996-1000.
17. Sanidas, I., Polytarchou, C., Hatziapostolou, M., Ezell, S. A., Kottakis, F., Hu, L., Guo, A., Xie, J., Comb, M. J., Iliopoulos, D. et al. (2014) Phosphoproteomics screen reveals akt isoform-specific signals linking RNA processing to lung cancer. Mol. Cell, 53, 577-590.
18. Pradeepa, M. M., Sutherland, H. G., Ule, J., Grimes, G. R. and Bickmore, W. A. (2012) Psip1/Ledgf p52 binds methylated histone H3K36 and splicing factors and contributes to the regulation of alternative splicing. PLoS Genet., 8, e1002717.
19. Sims, R. J. III, Millhouse, S., Chen, C. F., Lewis, B. A., Erdjument-Bromage, H., Tempst, P., Manley, J. L. and Reinberg, D. (2007) Recognition of trimethylated histone H3 lysine 4 facilitates the recruitment of transcription postinitiation factors and pre-mRNA splicing. Mol. Cell, 28, 665-676.
20. de Almeida, S. F., Grosso, A. R., Koch, F., Fenouil, R., Carvalho, S., Andrade, J., Levezinho, H., Gut, M., Eick, D., Gut, I. et al. (2011) Splicing enhances recruitment of methyltransferase HYPB/Setd2 and methylation of histone H3 Lys36. Nat. Struct. Mol. Biol., 18, 977-983.
21. Cheutin, T., McNairn, A. J., Jenuwein, T., Gilbert, D. M., Singh, P. B. and Misteli, T. (2003) Maintenance of stable heterochromatin domains by dynamic HP1 binding. Science, 299, 721-725.
22. Snowden, A. W., Gregory, P. D., Case, C. C. and Pabo, C. O. (2002) Gene-specific targeting of H3K9 methylation is sufficient for initiating repression in vivo. Curr. Biol., 12, 2159-2166.
23. Birmingham, A., Selfors, L. M., Forster, T., Wrobel, D., Kennedy, C. J., Shanks, E., Santoyo-Lopez, J., Dunican, D. J., Long, A., Kelleher, D. et al. (2009) Statistical methods for analysis of high-throughput RNA interference screens. Nat. Methods, 6, 569-575.
24. Boutros, M., Bras, L. P. and Huber, W. (2006) Analysis of cell-based RNAi screens. Genome Biol., 7, R66.
25. Stoilov, P., Lin, C. H., Damoiseaux, R., Nikolic, J. and Black, D. L. (2008) A high-throughput screening strategy identifies cardiotonic steroids as alternative splicing modulators. Proc. Natl Acad. Sci. U. S. A., 105, 11218-11223.
26. Jiang, Z., Tang, H., Havlioglu, N., Zhang, X., Stamm, S., Yan, R. and Wu, J. Y. (2003) Mutations in tau gene exon 10 associated with FTDP-17 alter the activity of an exonic splicing enhancer to interact with Tra2 beta. J. Biol. Chem., 278, 18997-19007.
27. Verkhusha, V. V., Kuznetsova, I. M., Stepanenko, O. V., Zaraisky, A. G., Shavlovsky, M. M., Turoverov, K. K. and Uversky, V. N. (2003) High stability of Discosoma DsRed as compared to Aequorea EGFP. Biochemistry, 42, 7879-7884.
28. Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T. et al. (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet., 25, 25-29.
29. Song, C. Z., Keller, K., Murata, K., Asano, H. and Stamatoyannopoulos, G. (2002) Functional interaction between coactivators CBP/p300, PCAF, and transcription factor FKLF2. J. Biol. Chem., 277, 7029-7036.
30. Xu, W., Seok, J., Mindrinos, M. N., Schweitzer, A. C., Jiang, H., Wilhelmy, J., Clark, T. A., Kapur, K., Xing, Y., Faham, M. et al. (2011) Human transcriptome array for high-throughput clinical studies. Proc. Natl Acad. Sci. U. S. A., 108, 3707-3712.
31. Downey, T. (2006) Analysis of a multifactor microarray study using Partek genomics solution. Methods Enzymol., 411, 256-270.
32. Seok, J., Xu, W., Gao, H., Davis, R. W. and Xiao, W. (2012) JETTA: junction and exon toolkits for transcriptome analysis. Bioinformatics, 28, 1274-1275.
33. Tachibana, M., Ueda, J., Fukuda, M., Takeda, N., Ohta, T., Iwanari, H., Sakihama, T., Kodama, T., Hamakubo, T. and Shinkai, Y. (2005) Histone methyltransferases G9a and GLP form heteromeric complexes and are both crucial for methylation of euchromatin at H3-K9. Genes Dev., 19, 815-826.
34. Shinkai, Y. and Tachibana, M. (2011) H3K9 methyltransferase G9a and the related molecule GLP. Genes Dev., 25, 781-788.
35. Nakayama, J., Rice, J. C., Strahl, B. D., Allis, C. D. and Grewal, S. I. (2001) Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly. Science, 292, 110-113.
36. Tachibana, M., Matsumura, Y., Fukuda, M., Kimura, H. and Shinkai, Y. (2008) G9a/GLP complexes independently mediate H3K9 and DNA methylation to silence transcription. EMBO J., 27, 2681-2690.
37. Ferrara, N., Gerber, H. P. and LeCouter, J. (2003) The biology of VEGF and its receptors. Nat. Med., 9, 669-676.
38. Carmeliet, P., Ng, Y. S., Nuyens, D., Theilmeier, G., Brusselmans, K., Cornelissen, I., Ehler, E., Kakkar, V. V., Stalmans, I., Mattot, V. et al. (1999) Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat. Med., 5, 495-502.
39. Zhang, H. T., Scott, P. A., Morbidelli, L., Peak, S., Moore, J., Turley, H., Harris, A. L., Ziche, M. and Bicknell, R. (2000) The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo. Br. J. Cancer, 83, 63-68.
40. Herve, M. A., Buteau-Lozano, H., Vassy, R., Bieche, I., Velasco, G., Pla, M., Perret, G., Mourah, S. and Perrot-Applanat, M. (2008) Overexpression of vascular endothelial growth factor 189 in breast cancer cells leads to delayed tumor uptake with dilated intratumoral vessels. Am. J. Pathol., 172, 167-178.
41. Grunstein, J., Masbad, J. J., Hickey, R., Giordano, F. and Johnson, R. S. (2000) Isoforms of vascular endothelial growth factor act in a coordinate fashion To recruit and expand tumor vasculature. Mol. Cell. Biol., 20, 7282-7291.
42. Mineur, P., Colige, A. C., Deroanne, C. F., Dubail, J., Kesteloot, F., Habraken, Y., Noel, A., Voo, S., Waltenberger, J., Lapiere, C. M. et al. (2007) Newly identified biologically active and proteolysis-resistant VEGF-A isoform VEGF111 is induced by genotoxic agents. J. Cell Biol., 179, 1261-1273.
43. Kubicek, S., O'Sullivan, R. J., August, E. M., Hickey, E. R., Zhang, Q., Teodoro, M. L., Rea, S., Mechtler, K., Kowalski, J. A., Homon, C. A. et al. (2007) Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase. Mol. Cell, 25, 473-481.
44. Bannister, A. J., Zegerman, P., Partridge, J. F., Miska, E. A., Thomas, J. O., Allshire, R. C. and Kouzarides, T. (2001) Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature, 410, 120-124.
45. Lachner, M., O'Carroll, D., Rea, S., Mechtler, K. and Jenuwein, T. (2001) Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature, 410, 116-120.
46. Canzio, D., Larson, A. and Narlikar, G. J. (2014) Mechanisms of functional promiscuity by HP1 proteins. Trends Cell Biol., 24, 377-386.
47. Smallwood, A., Hon, G. C., Jin, F., Henry, R. E., Espinosa, J. M. and Ren, B. (2012) CBX3 regulates efficient RNA processing genome-wide. Genome Res., 22, 1426-1436.
48. Nowak, D. G., Woolard, J., Amin, E. M., Konopatskaya, O., Saleem, M. A., Churchill, A. J., Ladomery, M. R., Harper, S. J. and Bates, D. O. (2008) Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors. J. Cell Sci., 121, 3487-3495.
49. Lee, J. S., Kim, Y., Kim, I. S., Kim, B., Choi, H. J., Lee, J. M., Shin, H. J., Kim, J. H., Kim, J. Y., Seo, S. B. et al. (2010) Negative regulation of hypoxic responses via induced Reptin methylation. Mol. Cell, 39, 71-85.
50. Wang, Z., Yang, D., Zhang, X., Li, T., Li, J., Tang, Y. and Le, W. (2011) Hypoxia-induced down-regulation of neprilysin by histone modification in mouse primary cortical and hippocampal neurons. PLoS One, 6, e19229.
51. Chen, H., Yan, Y., Davidson, T. L., Shinkai, Y. and Costa, M. (2006) Hypoxic stress induces dimethylated histone H3 lysine 9 through histone methyltransferase G9a in mammalian cells. Cancer Res., 66, 9009-9016.
52. Lee, S. H., Kim, J., Kim, W. H. and Lee, Y. M. (2009) Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells. Oncogene, 28, 184-194.
53. Lee, J. S., Kim, Y., Bhin, J., Shin, H. J., Nam, H. J., Lee, S. H., Yoon, J. B., Binda, O., Gozani, O., Hwang, D. et al. (2011) Hypoxia-induced methylation of a pontin chromatin remodeling factor. Proc. Natl Acad. Sci. U. S. A., 108, 13510-13515.
54. Arcondeguy, T., Lacazette, E., Millevoi, S., Prats, H. and Touriol, C. (2013) VEGF-A mRNA processing, stability and translation: a paradigm for intricate regulation of gene expression at the post-transcriptional level. Nucleic Acids Res., 41, 7997-8010.
55. Brody, Y. and Shav-Tal, Y. (2011) Transcription and splicing: when the twain meet. Transcription, 2, 216-220.
56. Spies, N., Nielsen, C. B., Padgett, R. A. and Burge, C. B. (2009) Biased chromatin signatures around polyadenylation sites and exons. Mol. Cell, 36, 245-254.
57. Dhami, P., Saffrey, P., Bruce, A. W., Dillon, S. C., Chiang, K., Bonhoure, N., Koch, C. M., Bye, J., James, K., Foad, N. S. et al. (2010) Complex exon-intron marking by histone modifications is not determined solely by nucleosome distribution. PLoS One, 5, e12339.
58. Allo, M., Buggiano, V., Fededa, J. P., Petrillo, E., Schor, I., de la Mata, M., Agirre, E., Plass, M., Eyras, E., Elela, S. A. et al. (2009) Control of alternative splicing through siRNA-mediated transcriptional gene silencing. Nat. Struct. Mol. Biol., 16, 717-724.
59. Saint-Andre, V., Batsche, E., Rachez, C. and Muchardt, C. (2011) Histone H3 lysine 9 trimethylation and HP1gamma favor inclusion of alternative exons. Nat. Struct. Mol. Biol., 18, 337-344.
60. Hon, G., Wang, W. and Ren, B. (2009) Discovery and annotation of functional chromatin signatures in the human genome. PLoS Comput. Biol., 5, e1000566.
61. Schor, I. E., Fiszbein, A., Petrillo, E. and Kornblihtt, A. R. (2013) Intragenic epigenetic changes modulate NCAM alternative splicing in neuronal differentiation. EMBO J., 32, 2264-2274.
62. Galiana-Arnoux, D., Lejeune, F., Gesnel, M. C., Stevenin, J., Breathnach, R. and Del Gatto-Konczak, F. (2003) The CD44 alternative v9 exon contains a splicing enhancer responsive to the SR proteins 9G8, ASF/SF2, and SRp20. J. Biol. Chem., 278, 32943-32953.
63. Clifford, R. L., John, A. E., Brightling, C. E. and Knox, A. J. (2012) Abnormal histone methylation is responsible for increased vascular endothelial growth factor 165a secretion from airway smooth muscle cells in asthma. J. Immunol., 189, 819-831.
64. Blanco, F. J. and Bernabeu, C. (2012) The Splicing Factor SRSF1 as a Marker for Endothelial Senescence. Front. Physiol., 3, 54.